This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Gangadhara Reddy Sareddy: Innovator in Cancer Therapy
Introduction
Gangadhara Reddy Sareddy is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on the targeting of PELP1, a protein involved in oncogenic signaling in cancers.
Latest Patents
Gangadhara Reddy Sareddy holds a patent titled "Targeting of PELP1 in cancer therapy." This patent describes PELP1 binding peptides and peptoids, which are crucial for understanding the interaction of PELP1 with molecules that lead to cancer progression. His innovative approach aims to enhance therapeutic strategies against cancer.
Career Highlights
Sareddy is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment. With a focus on molecular interactions, he continues to explore new avenues for therapeutic development.
Collaborations
Some of his notable coworkers include Ratna K Vadlamudi and Monica Mann. Their collaborative efforts contribute to advancing research in cancer therapy and related fields.
Conclusion
Gangadhara Reddy Sareddy is a pioneering inventor whose work in targeting PELP1 has the potential to transform cancer therapy. His contributions to the field highlight the importance of innovative research in combating cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile